Article Details

Cytovia Therapeutics Presents New Preclinical Data for Its GPC3 Flex-NK™ Cell Engager ...

Retrieved on: 2022-09-12 06:01:19

Tags for this article:

Click the tags to see associated articles and topics

Cytovia Therapeutics Presents New Preclinical Data for Its GPC3 Flex-NK™ Cell Engager .... View article details on hiswai:

Excerpt

The second complementary cornerstone technology is a quadrivalent multifunctional antibody platform designed to engage natural killer cells by ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up